Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q2)Feb 28, 2026 | (Q1)Nov 30, 2025 | (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -21.21%-5.51M | 89.63%-640K | 194.56%3.63M | 61.27%5.64M | -19.21%8.7M | 43.05%-4.55M | -22.00%-6.17M | 110.98%1.23M | -47.10%3.5M | 109.02%10.77M |
| Net income from continuing operations | 110.43%22K | 25.38%583K | -38.83%2.56M | 411.46%1.47M | -51.83%841K | 75.61%-211K | -87.69%465K | 137.05%4.19M | 92.76%-471K | 19.18%1.75M |
| Operating gains losses | 173.39%171K | 91.52%-24K | -80.29%69K | -79.50%41K | 1,022.03%544K | -410.67%-233K | -311.19%-283K | 126.96%350K | -15.25%200K | 95.98%-59K |
| Depreciation and amortization | -15.37%391K | -9.84%403K | -13.68%1.79M | -12.50%406K | 4.90%471K | -21.43%462K | -21.30%447K | -22.57%2.07M | -42.00%464K | -29.29%449K |
| Asset impairment expenditure | ---- | ---- | --560K | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Remuneration paid in stock | -86.15%9K | --0 | 0.00%259K | 0.00%64K | 1.56%65K | 0.00%65K | -1.52%65K | 9.28%259K | 1.59%64K | -1.54%64K |
| Other non cashItems | -43.35%358K | 23.92%316K | 112.64%807K | -86.02%46K | -145.16%-126K | 175.98%632K | 103.53%255K | -499.69%-6.38M | -33.94%329K | -49.73%279K |
| Change In working capital | -22.81%-6.46M | 73.07%-1.92M | -422.30%-2.41M | 24.24%3.62M | -23.45%6.35M | 34.84%-5.26M | -198.49%-7.12M | 107.58%749K | -42.53%2.91M | 112.67%8.29M |
| -Change in receivables | 34.46%-1.82M | 199.64%1.65M | -310.09%-5.5M | -154.28%-1.26M | 107.67%195K | -608.99%-2.77M | -172.42%-1.66M | -75.49%2.62M | 18.44%2.33M | -766.93%-2.54M |
| -Change in prepaid assets | 21.15%-246K | -140.71%-263K | -281.91%-1.28M | -123.18%-1.22M | -279.63%-388K | -140.00%-312K | -44.50%646K | 189.66%702K | -744.71%-548K | 517.14%216K |
| -Change in payables and accrued expense | -116.65%-5.78M | 82.36%-935K | 235.17%4.58M | 1,858.62%6.25M | -37.94%6.3M | 65.67%-2.67M | 12.99%-5.3M | 80.58%-3.39M | -86.88%319K | 173.29%10.15M |
| -Change in other current liabilities | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -199.94%-1.61M | -99.94%1K | --0 |
| -Change in other working capital | 180.32%1.38M | -192.00%-2.37M | -109.07%-220K | -117.65%-144K | -48.19%243K | 202.07%493K | -150.00%-812K | 161.67%2.43M | 180.08%816K | 303.91%469K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -21.21%-5.51M | 89.63%-640K | 194.56%3.63M | 61.27%5.64M | -19.21%8.7M | 43.05%-4.55M | -22.00%-6.17M | 110.98%1.23M | -47.10%3.5M | 109.02%10.77M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 885.98%7.57M | -1,102.27%-5.74M | -190.04%-4.83M | -452.92%-4.08M | 47.65%-367K | -834.95%-963K | 558.40%573K | 53.67%-1.67M | -224.67%-737K | -349.36%-701K |
| Net PPE purchase and sale | 6.85%-68K | -1,226.09%-610K | 15.00%-391K | -58.49%-168K | 27.27%-104K | 57.31%-73K | -15.00%-46K | -175.45%-460K | -411.76%-106K | -0.70%-143K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- |
| Net investment purchase and sale | --8.36M | ---4.24M | -103,175.00%-4.12M | ---4.12M | --0 | --0 | --0 | -92.59%4K | --0 | --0 |
| Net other investing changes | 18.76%-723K | -244.75%-896K | 73.72%-318K | 130.90%195K | 56.63%-242K | ---890K | 3,047.62%619K | -22.35%-1.21M | ---631K | -3,885.71%-558K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 885.98%7.57M | -1,102.27%-5.74M | -190.04%-4.83M | -452.92%-4.08M | 47.65%-367K | -834.95%-963K | 558.40%573K | 53.67%-1.67M | -224.67%-737K | -349.36%-701K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -34.22%-710K | -18.52%-512K | -7.94%-2.07M | -33.33%-560K | -62.69%-545K | 14.12%-529K | 20.44%-432K | -388.25%-1.91M | -117.31%-420K | 36.91%-335K |
| Net issuance payments of debt | 25.39%-335K | 1.16%-427K | 7.73%-1.77M | -5.95%-445K | -31.34%-440K | 27.11%-449K | 20.44%-432K | 11.96%-1.91M | -1.94%-420K | 36.91%-335K |
| Net common stock issuance | -1,233.33%-80K | ---11K | ---78K | ---42K | ---30K | ---6K | --0 | --0 | --0 | --0 |
| Cash dividends paid | -298.65%-295K | ---74K | ---222K | ---73K | ---75K | ---74K | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -34.22%-710K | -18.52%-512K | -7.94%-2.07M | -33.33%-560K | -62.69%-545K | 14.12%-529K | 20.44%-432K | -388.25%-1.91M | -117.31%-420K | 36.91%-335K |
| Net cash flow | ||||||||||
| Beginning cash position | -30.37%9.55M | -16.29%16.44M | -10.97%19.63M | -10.93%15.44M | 3.12%7.8M | -15.87%13.72M | -10.97%19.63M | -38.17%22.05M | 30.35%17.34M | -14.30%7.56M |
| Current changes in cash | 122.36%1.35M | -14.31%-6.9M | -39.22%-3.27M | -56.96%1.01M | -19.98%7.79M | 30.60%-6.04M | -5.31%-6.03M | 83.41%-2.35M | -73.43%2.34M | 117.98%9.74M |
| Effect of exchange rate changes | -197.32%-109K | -89.08%13K | 200.00%71K | 66.67%-16K | -434.88%-144K | 319.61%112K | 893.33%119K | -113.15%-71K | 23.81%-48K | 186.67%43K |
| End cash Position | 38.47%10.8M | -30.37%9.55M | -16.29%16.44M | -16.29%16.44M | -10.93%15.44M | 3.12%7.8M | -15.87%13.72M | -10.97%19.63M | -10.97%19.63M | 30.35%17.34M |
| Free cash from | -20.77%-5.58M | 79.90%-1.25M | 319.43%3.24M | 61.36%5.48M | -19.10%8.6M | 43.34%-4.62M | -21.94%-6.22M | 106.78%772K | -48.96%3.39M | 112.09%10.63M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.